Name: Adherium (ADR) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

ADR

Health Care Equipment & Services

Adherium

Short interest: 0.20%; +0.18 pp 30d; as of 14 Feb 2023
Reported shorts: 10M
Shares on issue: 4.996B

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Adherium

Adherium Limited specializes in digital health solutions, focusing on developing and manufacturing devices to monitor patient adherence to respiratory therapies. They position themselves as leaders in integrating advanced technology with healthcare services, enabling better management of chronic respiratory conditions like asthma and COPD. Adherium's unique value lies in their proprietary smart inhalers that provide real-time data to both patients and healthcare providers.

Company profile →

Adherium (ASX:ADR) has 0.20% of its shares on issue reported as short positions as of 14 Feb 2023, or about 10,000,000 shares. Over the past 30 days that figure has risen 0.18 percentage points, and over 90 days it has risen 0.18 percentage points. ADR is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads ADR today

Zanger BreakoutWatchScore 20rank 1274 of 1942
CAN SLIMWatchScore 9rank 1223 of 1541
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutWatchScore 15rank 579 of 1500
Quality compoundersWatchScore 10rank 1132 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

ADR fundamentals

In the year to 30 Jun 2026, Adherium (ASX:ADR) recorded revenue of A$3.2M and a net loss after tax of A$14.2M. A year earlier it recorded revenue of A$2.0M and a net loss after tax of A$12.7M. Year-on-year growth: revenue +59.1% (FY). Net margin −443.3% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →